A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure-Reference-Cited by-同舟云学术

A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure

Published:2008-04-20 Issue:5 Volume:14 Page:510-517
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Liggett Stephen B,Cresci Sharon,Kelly Reagan J,Syed Faisal M,Matkovich Scot J,Hahn Harvey S,Diwan Abhinav,Martini Jeffrey S,Sparks Li,Parekh Rohan R,Spertus John A,Koch Walter J,Kardia Sharon L R,Dorn II Gerald W

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1750.pdf

Reference48 articles.

1. Levy, D. et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347, 1397–1402 (2002).

2. Roger, V.L. et al. Trends in heart failure incidence and survival in a community-based population. J. Am. Med. Assoc. 292, 344–350 (2004).

3. Franz, W.M., Muller, O.J. & Katus, H.A. Cardiomyopathies: from genetics to the prospect of treatment. Lancet 358, 1627–1637 (2001).

4. The Merit HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353, 2001–2007 (1999).

5. The β-Blocker Evaluation of Survival Trial Investigators. A trial of the β-blocker bucindolol in patients with advanced chronic heart failure. N. Engl. J. Med. 344, 1659–1667 (2001).

Cited by 287 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-trait analysis reveals risk loci for heart failure and the shared genetic etiology with blood lipids, blood pressure, and blood glucose;Cell Reports;2024-09

2. Genetic Variants of the Beta-Adrenergic Receptor Pathways as Both Risk and Protective Factors for Retinopathy of Prematurity;American Journal of Ophthalmology;2024-07

3. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy;Clinical Pharmacology & Therapeutics;2024-07

4. Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression;Frontiers in Pediatrics;2024-01-16

5. Unravelling the influence of host genetic factors on malaria susceptibility in Asian populations;Acta Tropica;2024-01